Pathstone Holdings’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $671K | Sell |
20,630
-2,117
| -9% | -$68.8K | ﹤0.01% | 1579 |
|
|
2025
Q1 | $859K | Sell |
22,747
-8,794
| -28% | -$332K | ﹤0.01% | 1460 |
|
|
2024
Q4 | $2.58M | Buy |
31,541
+1,014
| +3% | +$83K | 0.01% | 842 |
|
|
2024
Q3 | $3.49M | Buy |
30,527
+2,154
| +8% | +$246K | 0.02% | 692 |
|
|
2024
Q2 | $2.14M | Buy |
28,373
+5,100
| +22% | +$385K | 0.01% | 896 |
|
|
2024
Q1 | $1.59M | Buy |
23,273
+19,516
| +519% | +$1.33M | 0.01% | 1024 |
|
|
2023
Q4 | $236K | Buy |
+3,757
| New | +$236K | ﹤0.01% | 1971 |
|